Professor Charlotte Coles receives top honour from Royal College of Radiologists
18 Sep 2023
Congratulations to Professor Charlotte Coles, CRUK RadNet Cambridge lead on being awarded the Gold Medal by the Royal College of Radiologists.
Cambridge cancer survivor stars in national ad campaign
1 Sep 2023
New Cancer Research UK funding drive launched as analysis shows over a million lives saved from cancer since the 1980s.
Treatment hopes for most deadly childhood brain tumours
1 Sep 2023
Cambridge scientists join team exploring the role of senescent (non-growing) cells in childhood brain tumour development and recurrence, in new research funded by The Brain Tumour Charity.
First patient recruited in Cambridge for novel cancer immunotherapy trial
31 Aug 2023
A new clinical trial is being carried out by CRUK’s Centre for Drug Development to evaluate the orally available drug, HTL0039732, for advanced solid tumours.
Scientists develop test to identify people at risk of developing acute myeloid leukaemia and related cancers
24 Aug 2023
The new platform, called ‘MN-predict’, will allow doctors and scientists to identify those at risk and to design new treatments to prevent them from developing these potentially lethal cancers.
International collaboration identifies new breast cancer susceptibility genes
17 Aug 2023
The study, published today in Nature Genetics, was led by teams at the University of Cambridge and Université Laval, Quebec.
Major milestones reached for new East of England cancer hospital
8 Aug 2023
Cambridge Cancer Research Hospital (CCRH) has had the second stage of its business case, its Outline Business Case, approved by NHS England, the Department of Health and Social Care and HM Treasury.
World Head and Neck Cancer Day 2023
25 Jul 2023
To mark World Head and Neck Cancer Day on Thursday 27 July, our research and clinical teams ran an information and activity stand in the Oncology Day Unit at Addenbrooke’s.
Funding for new approach to detect and treat therapy-resistant lung cancer
11 Jul 2023
£650,000 has been awarded to develop novel imaging, AI-methods, and targeted treatment for therapy-resistant lung cancer.
Celebrating 75 years of the NHS
5 Jul 2023
Our cutting edge cancer research would not be possible without our strong partnership between Cancer Research UK, Cambridge University Hospitals and the University of Cambridge.
